Greenwood Capital Associates LLC Has $623,000 Stock Position in SWK Holdings Co. (NASDAQ:SWKH)

Greenwood Capital Associates LLC cut its stake in SWK Holdings Co. (NASDAQ:SWKH) by 3.8% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 39,311 shares of the company’s stock after selling 1,543 shares during the quarter. Greenwood Capital Associates LLC’s holdings in SWK were worth $623,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also modified their holdings of the company. Dimensional Fund Advisors LP lifted its holdings in SWK by 85.7% during the 2nd quarter. Dimensional Fund Advisors LP now owns 30,109 shares of the company’s stock valued at $511,000 after purchasing an additional 13,892 shares during the last quarter. Victory Capital Management Inc. bought a new position in shares of SWK in the third quarter valued at approximately $589,000. Barclays PLC boosted its holdings in shares of SWK by 185.0% in the 3rd quarter. Barclays PLC now owns 4,461 shares of the company’s stock worth $77,000 after acquiring an additional 2,896 shares in the last quarter. JPMorgan Chase & Co. grew its position in SWK by 224.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 6,108 shares of the company’s stock worth $106,000 after acquiring an additional 4,225 shares during the last quarter. Finally, SkyView Investment Advisors LLC increased its holdings in SWK by 2.1% during the 3rd quarter. SkyView Investment Advisors LLC now owns 31,815 shares of the company’s stock valued at $550,000 after purchasing an additional 650 shares in the last quarter. Institutional investors own 99.27% of the company’s stock.

SWK Trading Up 0.4 %

Shares of SWKH opened at $16.46 on Wednesday. The stock has a fifty day moving average price of $16.22 and a two-hundred day moving average price of $16.66. The company has a debt-to-equity ratio of 0.11, a quick ratio of 5.06 and a current ratio of 5.06. The company has a market cap of $201.31 million, a price-to-earnings ratio of 17.70 and a beta of 0.37. SWK Holdings Co. has a 52-week low of $15.14 and a 52-week high of $18.49.

SWK Profile

SWK Holdings Corporation, offers specialty finance and asset management services in the United States. It operates in two segments, Finance Receivables and Pharmaceutical Development. The Finance Receivables segment provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors.